We are pleased to announce that we are the first practice in the State of Iowa to have performed collagen cross-linking!
Collagen cross-linking (CXL) is the newest FDA approved treatment for keratoconus, a blinding disease of the cornea.
While in Oklahoma, Dr. Cohen was a principal investigator for the Avedro clinical trial. Avedro, the company that developed this technology for use in the U.S., announced in April of 2016 that the FDA has finally approved this treatment. During the trial, Dr. Cohen had the opportunity to treat and follow many patients over multiple years. He has more experience with this technology than anyone in the state of Iowa and is pleased to offer this life changing treatment.
If you or someone you know has keratoconus please call our office today for an evaluation.